XiaoweiWilliamSuMDPhD

Clinical Trials

• HEALEY ALS Platform Trial - Master Protocol Start of enrollment: 2020 Jul 14

  Active, not recruiting

  Phase 2, Phase 3

• HEALEY ALS Platform Trial - Regimen C CNM-Au8 Start of enrollment: 2020 Jul 30

  Completed

  Phase 2, Phase 3

• HEALEY ALS Platform Trial - Regimen A Zilucoplan Start of enrollment: 2020 Jul 29

  Completed

  Phase 2, Phase 3

• HEALEY ALS Platform Trial - Regimen B Verdiperstat Start of enrollment: 2020 Jul 28

  Completed

  Phase 2, Phase 3

• HEALEY ALS Platform Trial - Regimen D Pridopidine Start of enrollment: 2020 Dec 18

  Completed

  Phase 2, Phase 3

• Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2020 Oct 29

  Completed

  Phase 3

• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2021 Aug 16

  Terminated

  Phase 3

• Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS Start of enrollment: 2022 Jan 11

  Terminated

  Phase 3

• HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose Start of enrollment: 2022 Feb 21

  Completed

  Phase 2, Phase 3

• Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2022 Apr 13

  Terminated

  Phase 2

• HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262 Start of enrollment: 2023 Mar 23

  Enrolling by invitation

  Phase 2, Phase 3

• Intermediate Expanded Access Protocol (EAP) CNMAu8.EAP02

  Available

• HEALEY ALS Platform Trial - Regimen G DNL343 Start of enrollment: 2023 May 24

  Enrolling by invitation

  Phase 2, Phase 3

• Intermediate Expanded Access Protocol CNMAu8.EAP04

  Available

• Join now to see all